ケンタッキー州における卵巣がんの臨床試験
ケンタッキー州内の拠点で、卵巣がんに関する25件の研究が参加者を募集しています。
ケンタッキー州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0251 - Norton Cancer Institute, Louisville
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT05128825A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Baptist Health Lexington /ID# 275218, Lexington
- Norton Cancer Institute - St. Matthews /ID# 276173, Louisville
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT06890338A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Baptist Health Lexington /ID# 278267, Lexington
被験者募集中第2相
18歳以上 · 女性 · 2026/09/22更新 · NCT07059845A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Baptist Health Lexington, Lexington
- Norton Women's and Children's Hospital, Louisville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Norton Cancer Institute, Louisville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Norton Cancer Institute, Louisville
被験者募集中第2相
18歳〜99歳 · 女性 · 2026/09/15更新 · NCT07023627Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- St Elizabeth Healthcare, Edgewood
被験者募集中第3相
18歳以上 · 女性 · 2026/09/15更新 · NCT07214779FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Norton Cancer Institute Research, Louisville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06303505Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- Norton Cancer Institute, St. Matthews Clinic, Louisville
被験者募集中第2相
18歳以上 · 女性 · 2026/09/14更新 · NCT06787612A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- St. Elizabeth Healthcare, Edgewood
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06774963Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- University of Kentucky/Markey Cancer Center, Lexington
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07001748A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Baptist Health Corbin, Corbin
- Baptist Health Lexington, Lexington
- Norton Hospital Pavilion and Medical Campus, Louisville
- 他5件
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Baptist Health Corbin, Corbin
- Commonwealth Cancer Center-Corbin, Corbin
- 他10件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- St. Elizabeth Medical Center, Edgewood
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/07/28更新 · NCT06161025Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Kentucky, Lexington
被験者募集中第1/2相
18歳〜90歳 · 全性別 · 2026/07/06更新 · NCT06710756EXoPERT EMERALD Clinical Study
- Lexington VA Healthcare System, Lexington
- KCTL, Louisville
被験者募集中観察研究健康なボランティア歓迎
45歳以上 · 全性別 · 2026/07/01更新 · NCT07186296A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
- St. Elizabeth Medical Center - Edgewood /ID# 272113, Edgewood
- Baptist Health Lexington /ID# 272211, Lexington
被験者募集中第2相
18歳以上 · 女性 · 2026/05/26更新 · NCT06682988Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- University of Kentucky Medical Center, Lexington
被験者募集中第3相
18歳以上 · 女性 · 2026/04/16更新 · NCT05659381Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
- University of Kentucky, Lexington
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/01更新 · NCT04779554Combination Therapy for Recurrent Ovarian Cancer
- UofL Health Brown Cancer Center, Louisville
被験者募集中第1/2相
18歳以上 · 女性 · 2026/03/19更新 · NCT05610735A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- University of Kentucky Markey Cancer Center, Lexington
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863First in Human Study of TORL-1-23 in Participants With Advanced Cancer
- University of Kentucky Medical Center, Lexington
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT05103683cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Corbin, Corbin
- Baptist Hardin, Elizabethtown
- Baptist Lexington, Lexington
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- Markey Cancer Center, Lexington
被験者募集中健康なボランティア歓迎
24歳以上 · 女性 · 2025/11/14更新 · NCT04473833ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。